Particles from combustion of fossil fuels may damage brain health more than thought, research suggests
Research suggests it could prevent and slow the progress of cognitive decline
Researchers find differences according to age and education and reveal men affected as much as women
Health secretary says there is a need to look at sharp increase ‘through a strictly clinical lens’
Outcome is blow to one of Europe’s largest listed companies
Research using data from Harvard Aging Brain Study showed more active patients saw slower cognitive deterioration
Results are due soon from two studies using semaglutide to treat thousands of people with the disease
I can’t afford to pay for costs out of my personal income but I don’t want to sell my property
Study of people living in US cities finds link with a type of the disease called Lewy body
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales
New competition is latest effort to deploy artificial intelligence to find cures for serious illnesses
Subtle changes that contribute to cognitive decline could be flying under the radar
Analysis of large biological dataset uncovers clues to help detect and combat neurodegenerative conditions
Oxford research shows adjuvant chemicals included in vaccinations may enhance their antiviral effect
European Medicines Agency says risks of potentially fatal side effects from donanemab outweigh benefits
Neurologist Masud Husain explores the ways that injury and disease transformed the lives of seven patients
Research adds to evidence that viral infections contribute to development of dementia
Drug company made claims even though a study of donanemab’s preventive potential is not due to end until 2027
Care home costs have been rising steeply
More trials urged as part of effort to slow cognitive declines with existing medicines
Nice’s ruling on lecanemab demonstrates the lack of readiness to roll out new treatments in the UK
Spending watchdog declines to give green light to lecanemab for patients in England
Reducing 14 ‘modifiable’ risks can prevent or delay cognitive disorder, report says
Eisai and Biogen face uphill battle to win EU approval for Leqembi after committee’s ruling
